Varex Imaging (VREX) Stock
Medical and industrial X-ray imaging component supplier. Here's the price, business snapshot, and what's worth knowing about Varex Imaging in October 2026.
Varex Imaging Corporation (VREX) designs and supplies X‑ray imaging components and subsystems used by medical, veterinary and industrial equipment makers. The company's products include X‑ray tubes, digital detectors and power electronics that feed into diagnostic imaging systems and non‑destructive testing machines. With a market capitalisation around $483.48M, Varex is positioned as a specialist supplier rather than an OEM, so revenue is linked to capital equipment cycles, hospital and clinical investment and industrial inspection demand. Investors should note drivers such as ageing populations, diagnostic upgrades and industrial automation, alongside risks including cyclical capital spending, pricing pressure from larger suppliers and supply‑chain sensitivity. The stock can be more volatile than large-cap healthcare names; values may rise or fall and past performance is not indicative of future returns. This summary is educational only and not personal financial advice — consider your risk tolerance, investment horizon and seek independent advice where appropriate.
Varex Imaging (VREX) Stock Forecast
Analyst price target, next 12 months
$21.82
+18.4% vs today's $18.43
Price range over the last 12 months
Close to its 12-month high
Analysts covering Varex Imaging have a consensus 12-month target of $21.82, above the current price of $18.43.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 27 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Varex Imaging's stock with a target price of $21.82, indicating modest growth potential.
Financial Health
Varex Imaging Corporation shows solid revenue and cash flow, indicating good overall financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Medical imaging demand
Ageing populations and diagnostic upgrades can drive steady demand for imaging components, though capital spending cycles can introduce volatility.
Component supplier role
Longstanding OEM relationships and specialised technology are strengths, but margins and order timing can vary with competitive and supply pressures.
Industrial and global reach
Sales span medical and industrial markets across regions, offering diversification, though global exposure brings currency and regulatory considerations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
